The "E" in Rave: A profile of young Ecstasy (MDMA) users

South African Journal of Psychology

Volumn 33, Issue 3, 2003, Pages 162-169

  Zervogiannis, F H ^a   Wischers, E ^b   Bester, G ^b  

^a University of South Africa ^*  (South Africa)

^b UNIVERSITY OF SOUTH AFRICA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0141592356     PISSN: 00812463     EISSN: None     Source Type: Journal    
DOI: 10.1177/008124630303300304     Document Type: Article

References (39)

1. Australian Drug Foundation. (1998). Jargon. Australian Drug Foundation. http://www.adf.org.au/drughit/keyterms.html. Accessed on 2 November 2001.
2. Ary, D., Jacobs, L. C. & Razavieh, A. (1990). Introduction to research in education. NewYork: Holt, Reinhart & Winston.
3. Battaglia, G., Yeh, S. Y. & De Souza, E. B. (1988). MDMA induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacology, Biochemistry and Behaviour, 29(2), 269-274.
4. Beck, J. & Morgan, P. (1986). Designer drug confusion: A focus on MDMA. Journal of Drug Education, 16 (3), 287-302.
5. Bell, J. (1997). Doing your research project. A guide for researchers in Education and Social Science. Second Edition. Philadelphia: Open University Press.
6. Benazzi, I. & Mazzoli, M. (1991). Psychiatric illness associated with Ecstasy. Lancet, 338(2), 1520.
7. Bolla, K. I., McCann, U. D., & Ricaurte, G. A. (1998). Memory Impairment in abstinent MDMA ("Ecstasy") users. Neurology. (http.//www.erowid.org/entheogens/mdma/ mdma_journal4/mdma_journal4_articlel.shtml). Accessed on 31 March 2003.
8. Brown, E. R. S., Jarvie, D. R. & Simpson, D. (1995). Use of drugs at "Raves". Scottish Medical Journal, 40(6), 168-171.
9. Cohen, R.S. (1995). Subjective reports on the effects of the MDMA ('Ecstasy') experience in humans. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 19 (7), 1137-1145.
10. Collin, M. (1997). Altered state. The story of ecstasy culture and acid house. New York: Serpent's Tail.
11. Doblin, R. (1995). MDMA neurotoxicity: New data, new risk analysis. Newsletter of the Multidisciplinary Association for Psychedelic Studies (MAPS), 6 (1). http://www.maps.org/news-letters/v06nl/061res.html. Accessed on 31 March 2003.
12. Eisner, B. (1989). Ecstasy. The MDMA story. Berkeley,Ca: Ronin Publishing.
13. Elk, C. (1996). MDMA (Ecstasy): Useful information for health professionals involved in drug education programs. Journal of Drug Education, 26 (4), 349-356.
14. Fischer, C., Hatzidimitriou, G., Wios, J., Katz, J. & Ricaurte, G. (1995). Reorganization of ascending 5-ht axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). Journal of Neuroscience ,15 (8), 5476-5485.
15. Gillis, H. (1994). Counselling Young People. A practical guide for parents, teachers, and those in helping professions. Pretoria: Kagiso Publishers.
16. Goode, E. (1993). Drugs in American society. New York: McGraw-Hill.
17. Granquist, L. (1995). Neurochemical markers and MDMA neurotoxicity. Newsletter of the Multidisciplinary Association for Psychedelic Studies (MAPS), 5 (3). http://www.maps.org/news-letters/v05n3/053res.html. Accessed on 31 March 2003.
18. Hayner, G. N. & Me Kinney, H. E. (1986). MDMA: The dark side of Ecstasy. Journal of Psychoactive Drugs, 18 (4), 341-347.
19. Jackson, S. (1998). Popular rave drug "Ecstasy" impairs memory, apparently related to brain damage. NIDA Media Advisory. http://www.health.org/pressrel/dec98/9.html. Accessed on 2 December 2001.
20. Jansen, K.L.R. (1997). Adverse psychological effects associated with the use of Ecstasy (MDMA) and their treatment. In N. Saunders (Ed.), Ecstasy Reconsidered (pp. 112 - 131). London: Nicholas Saunders.
21. Jones, C. (1997). Safety. In N. Saunders (Ed.), Ecstasy Reconsidered (pp. 200 - 209). London: Nicholas Saunders.
22. Jonker, K. (1996, November). The Rave scene in South Africa. Paper presented at the SA Narcotics Bureau: Ecstasy Conferenc, Paarl, South Africa.
23. Mathias, R. (1996). MDMA like Methamphetamine, "Ecstasy" may cause long-term brain damage. http://165.112.78.61/NIDA_Notes/NNVol11N5/Ecstasy.html Accessed 31 March 2003.
24. McCann, U. D. & Ricaurte, G. A. (1991). Lasting neuropsychiatric sequelae of methylenedioxymethamphetamine (Ecstasy) in recreational users. Journal of Clinical Psychopharmacology, 11 (5), 302-305.
25. nd ed.). Glenview, Illinois: Scott, Foresman.
26. Parker, H. (1995). Drugs futures: Changing patterns of drug use amongst English youth. Institute for the Study of Drug Dependency. http://www.druglibrary.org.schaffer/kids/ demos/demosr.html. Accessed on 11 November 2001.
27. Rave Safe (1997). Raver's guide. [S.1: s.n.] [no place name: no publisher's name].
28. Redhead, S. (1993). Rave off. Politics and deviance in contemporary youth culture. London: Avebury.
29. Reynolds, S. (1998). Energy flash. A journey through rave music and dance culture. London: Picador.
30. Ricaurte, G. (1997). Long term effects of 3,4 methylenedioxymethamphetamine (MDMA, "Ecstasy") on brain serotonin nerve cells in animals and humans. Addictions Research Journal. http://www.addictions.com/Addictions_1997_Article4.html. Accessed on 11 November 2001.
31. Rosenbaum, M. (1999). Safety first: A reality approach to teens, drugs and drug education. San Francisco: America Printing.
32. Rosenbaum, M. (1996). Kids, drugs and drug education. A harm reduction approach. San Francisco, California: National Council on Crime and Delinquency, Lindesmith Center.
33. nd ed.). Englewood Cliffs, NJ: Simon & Schuster.
34. Saunders, N. (1997). Ecstasy reconsidered. London: Nicholas Saunders.
35. Singer, G. G. & Brenner, B. M. (1998). Fluid and electrolyte disturbances. In E. Braumwald (Ed.), Harrison's principles of internal medicine (Chapter 49, pp. 1-17) (CD Rom). New York: McGraw-Hill.
36. Solowij, N., Hall, W. & Lee, N. (1992). Recreational MDMA use in Sydney: a profile of "Ecstasy" users and their experiences with the drug. British Journal of Addiction, 87 (8), 1161-1172.
37. Van Aerts, L. (1997). Toxicity. In N. Saunders (Ed.), Ecstasy Reconsidered (pp. 90 - 111). London: Nicholas Saunders.
38. White, J.M., Bochner, F & Irvine, R.J. (1997). The agony of "ecstasy". How can we avoid more "ecstasy" related deaths? The Medical Journal of Australia, 166(3), 117-118.
39. Williamson, K. (1997). Drugs and the party line. Edinburgh: Rebel Inc.